Medialab

Medialab

Research & Development

AFP Medialab is a small multi-disciplinary team aimed to boost innovation at AFP. It participates in several R&D projects with French or European funding. AFP Medialab is the main developer of the InVID-WeVerify browser extension, one of the main toolboxes to debunk disinformation. This toolbox has attracted more than 90,000 weekly active users from 224 countries at the beginning of 2023.

 

'What would you have us do?': the plastic credits problem

This investigation by AFP and SourceMaterial reveals that the plastic credits system relies heavily on cement plants, where large quantities of waste are incinerated, making this industry more polluting than aviation.

This investigation by AFP and SourceMaterial reveals that the plastic credits system relies heavily on cement plants, where large quantities of waste are incinerated, making this industry more polluting than aviation.

AFP successfully tests a new technology to verify the authenticity of its photos during the US elections

With the rise of generative AI and the growing use of synthetic images, Agence France-Presse (AFP) has successfully tested a “proof of concept” to certify the authenticity of its photos, ensuring they can be verified wherever they appear online. The Agency now plans to develop this technology further in collaboration with camera manufacturers, editing software developers, and news distributors, working towards a shared industry standard that protects the integrity of photojournalism.

With the rise of generative AI and the growing use of synthetic images, Agence France-Presse (AFP) has successfully tested a “proof of concept” to certify the authenticity of its photos, ensuring they can be verified wherever they appear online. The Agency now plans to develop this technology further in collaboration with camera manufacturers, editing software developers, and news distributors, working towards a shared industry standard that protects the integrity of photojournalism.
06/30/2025 12:00
Takeda Announces U.S. FDA Approval of GAMMAGARD LIQUID ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content1

Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved GAMMAGARD LIQUID ERC [immune globulin infusion (human)] with less than or equal to 2 µg/mL IgA in a 10% solution, the only ready-to-use liquid immunoglobulin (IG) therapy with low immunoglobulin A (IgA) content, as replacement therapy for people two years of age and older with primary immunodeficiency (PI). As a ready-to-use liquid, GAMMAGARD LIQUID ERC may help ease the administration burde...

Webinaire sur l'IA
Retour Retour
Webinaires

Fact-Checking in the Age of AI

Date
Thursday 21 August 2025 14:00 à 15:00 (UTC+8)
Lieu En ligne
Organisateur
Organised by AFP

AFP photographer Mahmud Hams wins top prize for Gaza coverage

Palestinian AFP photographer Mahmud Hams has won the prestigious Visa d'Or News prize for his coverage of the conflict in Gaza, the Visa pour l'image Association announced Saturday.

Palestinian AFP photographer Mahmud Hams has won the prestigious Visa d'Or News prize for his coverage of the conflict in Gaza, the Visa pour l'image Association announced Saturday.
05/30/2025 09:17
Indian Educationist Dr. Achyuta Samanta Recognised With Research Institute in His Name at CUNY, USA

In a noteworthy development underscoring growing academic collaboration between India and the United States, the City University of New York (CUNY) has launched a dedicated research platform—the Achyuta Samanta India Initiative of the CUNY CREST Institute (ASIICCI). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250529012005/en/Dr. Milton Santiago, President of Bronx Community College, and Dr. Achyuta Samanta, Founder of KIIT & ...

06/04/2025 05:00
Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse® G sTREM2 Assay for Research Use Only

H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G sTREM2 assay for the fully automated LUMIPULSE® G immunoassay analyzers. This CLEIA (chemiluminescent enzyme immunoassay) assay is available for Research Use Only (RUO) and allows for the quantitative measurement of soluble Triggering Receptor Expressed on Myeloid Cells 2 (sTREM2) in human cerebrospinal fluid (CSF) and blood within just 35 minutes. ...

AFP held fact-checking trainings before the 2025 International Fact-Checking Day

Four AFP journalists from the digital investigation department travelled to Sofia, Bucharest and Budapest, in March and April 2025 to provide fact-checking training to journalists and journalism students.

Four AFP journalists from the digital investigation department travelled to Sofia, Bucharest and Budapest, in March and April 2025 to provide fact-checking training to journalists and journalism students.

Newsflare joins AFP's partner video collections

AFP announces a partnership with video agency Newsflare, which specialises in collecting, verifying and licensing UGC videos.

AFP announces a partnership with video agency Newsflare, which specialises in collecting, verifying and licensing UGC videos.
Anglais
Subscribe to